Lundbeck
HLUN-B.CO
₹372.13
Share price
-0.83%
Change (1 day)
-5.37%
Change (1 year)
Categories
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.
P/S ratio for Lundbeck (HLUN-B.CO)
P/S ratio as of April 2025 (TTM): 1.33
According to Lundbeck 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.21. At the end of 2024 the company had a P/S ratio of 1.75.
P/S ratio history for Lundbeck from 2010 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 1.75 | 7.96% |
| 2023 | 1.62 | 15.97% |
| 2022 | 1.40 | 419.75% |
| 2021 | 0.2693 | -19.85% |
| 2020 | 0.3360 | -13.88% |
| 2019 | 0.3901 | -5.42% |
| 2018 | 0.4125 | -18.73% |
| 2017 | 0.5075 | 8.49% |
| 2016 | 0.4678 | 10.96% |
| 2015 | 0.4216 | 88.57% |
| 2014 | 0.2236 | -9.12% |
| 2013 | 0.2460 | 64.77% |
| 2012 | 0.1493 | -35.78% |
| 2011 | 0.2325 | 22.05% |
| 2010 | 0.1905 |